On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
HOME > REGULATORY
REGULATORY
- MHLW Subcommittee Agrees on Access System for Domestically Unapproved Drugs
October 20, 2011
- MHLW Presents Data at Chuikyo Supporting Reduction in 70% Rule for New Generics
October 20, 2011
- Cost of Advanced Healthcare Services Totaled ¥13.2 Billion in FY2010: Korosho
October 20, 2011
- HSC Subcommittee Considering Review of Refractory Diseases Eligible for Treatment Subsidies
October 20, 2011
- MHLW Revises Precautions for Use in OTC Drugs
October 19, 2011
- PMDA Presents Warnings on Website to Prevent Mistaken Use of 3 Taxane Drugs
October 19, 2011
- Korosho Proposes 80% Price Rule for Single-enantiomer Drugs
October 19, 2011
- Korosho Presents Direction for PAL Amendment in 2012
October 19, 2011
- Council to Set Up Committee to Discuss Creation of “Drug Discovery Support Organization”
October 18, 2011
- MHLW to Survey, Consider Measures for Clinical Trials in Coping with Earthquakes
October 17, 2011
- Health Minister Shows Positive Attitude Towards Participation in TPP Talks
October 17, 2011
- Vice Minister Tsuji Supports Continuation of Premium for New Drug Development
October 17, 2011
- Korosho Task Force Discusses Upcoming Switch to Inactivated Polio Vaccine
October 17, 2011
- Avastin Approved for Treatment of Breast Cancer in Combination with Paclitaxel
October 13, 2011
- Revision of Ryotan-kisoku to Be Considered to Control Dispensing Point Services
October 13, 2011
- Drug Expenditure Higher than Apparent Due to Hidden Drug Expenditure: Korosho
October 12, 2011
- Chuikyo to Discuss “Dispensing Points” Offered by Pharmacies
October 12, 2011
- Headquarters for Promotion of Social Security Reform Holds 1st Meeting
October 11, 2011
- Korosho Expresses Opposition to Break-Up, Privatization of PMDA
October 11, 2011
- HPV Vaccines Competing for Public Subsidies; Are Parents Avoiding Vaccination by OB/GYN Doctors?
October 10, 2011
ページ
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
As Japan’s budget season draws near, the Ministry of Finance (MOF) has renewed its push for a full-scale “off-year” drug…
Japan will trim the NHI price of Eli Lilly Japan’s Alzheimer’s treatment Kisunla (donanemab) by 3.93% under the cost-effectiveness assessment…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…